Malaria (a life-threatening disease) is the leading cause of parasitic disease transmitted through mosquitoes, which kills around half a million lives per year. So, finding a key solution to cure parasitic diseases is an existing concern among healthcare service providers. However, various pharmaceutical industries focus on finding an effective antimalarial solution.
Antimalarial medicines are considered lifesaving, not only as part of the treatment but also for the control of the disease. As a result, artemisinin combination therapy (ACT) is increasingly adopted among drug manufacturers and healthcare service providers as a major source of safe medicine and health treatment alternatives due to the rising applications in the pharmaceutical industry.
Understanding the Meaning of Artemisinin
Artemisinin is a drug that is derived from the extracts of sweet wormwood. It is native to China and is found to be effective in the treatment of malaria caused by plasmodium falciparum. It contains regimens, which are important to find effective treatments solution for multidrug-resistant malaria.
It is a medication that inhibits the metabolism of parasites more quickly compared to other antimalarials. It is widely used in the study of the treatment of malaria, schizophrenia, falciparum, and plasmodium falciparum. It is also effective for cancer treatment as it has anticancer properties in a range of cell lines and animal models supporting the hypothesis.
Some of the common side effects include nausea, vomiting, anorexia, and dizziness.
Why is Artemisinin-based Combination Therapy Becoming More Common?
Artemisinin is known to have antifungal, antibacterial, antioxidant, antileishmanial, antitumor, and anti-inflammatory activity. Artemisinin-based combination therapy is comprised of two components including an artemisinin derivative and a partner drug. This therapy is suggested for treating plasmodium falciparum malaria.
World Health Organization (WHO) has recommended artemisinin as a first-line treatment for malaria. However, artemisinin combination therapy is currently employed across the globe as it proved to be the most effective solution in the treatment.
Benefits and Side Effects of Artemisinin
Its key benefit is that it quickly reduces the majority of malaria parasites and the partner drug clears the remaining parasites. It has the ability to reduce transmission of the parasite compared to other treatments. This therapy is a promising approach that is highly recommended by physicians to overcome drug resistance.
It doesn’t mean that it won’t cause patients while treatment. Some of the common side effects include nausea, vomiting, anorexia, and dizziness.
Why Asia Pacific is a Key Destination for the Artemisinin Market?
The population of malaria patients is quite high in the region. Thus, the increasing requirement for treating malaria is estimated to propel the growth of the market in the Asia Pacific region. Furthermore, rising government initiatives toward healthcare facilities and preventing disease leads to encouraged physicians and the pharmaceutical industry to adopt artemisinin.
Market Valuation Insight
The acceptance of artemisinin is largely influenced by the high prevalence of malaria and the increasing awareness of the disease among people. Furthermore, rising government initiatives to control malaria are anticipated to propel the growth of the market.
With the trend, the global artemisinin market size was valued at USD 63 Million in 2020 and is projected to reach USD 217.5 Million by 2028, expanding at a CAGR of 19.2% during the forecast period, 2021–2028.
Yeshua-Bio-Tech; Guilin Pharmaceutical Co. Ltd; Sanofi Aventis; Shanghai Desano Chemical Pharmaceutical Co. Ltd; Kunming Pharmaceutical Corporation; Calyx Pharmaceuticals and Chemicals; and Mylan Laboratories Limited are some of the prominent players competing in the market. Some of these players are using several market strategies to enhance and generate their market shares and raise their production lines.
Get a Free Sample Report @ https://growthmarketreports.com/request-sample/2518
Conclusion
Artemisinin is an effective anti-malarial medicine, used for the treatment of uncomplicated and severe malaria in both adults and children. Safety and efficiency of ACT influence the healthcare sector to adopt it for treating malaria patients as it reduces the transmission of parasites. Moreover, the rising use of artemisinin plays a crucial role in generating more revenue share in the market.
